BR0104352A - Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais - Google Patents

Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais

Info

Publication number
BR0104352A
BR0104352A BR0104352-8A BR0104352A BR0104352A BR 0104352 A BR0104352 A BR 0104352A BR 0104352 A BR0104352 A BR 0104352A BR 0104352 A BR0104352 A BR 0104352A
Authority
BR
Brazil
Prior art keywords
taxanes
carbamoyloxy
substituted
antitumor agents
substituent
Prior art date
Application number
BR0104352-8A
Other languages
English (en)
Inventor
Robert A Holton
Weishuo Fang
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of BR0104352A publication Critical patent/BR0104352A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)

Abstract

Patente de Invenção: "TAXANOS SUBSTITUìDOS POR C10 CARBAMOILóXI COMO AGENTES ANTITUMORAIS". Os taxanos tendo um substituinte de carbamoilóxi em C(10), um substituinte de hidróxi em C(7), e uma faixa de C(2), C(9), C(14), e substituintes de cadeia lateral.
BR0104352-8A 2000-02-02 2001-02-02 Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais BR0104352A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17979300P 2000-02-02 2000-02-02
PCT/US2001/003633 WO2001057033A1 (en) 2000-02-02 2001-02-02 C10 carbamoyloxy substituted taxanes as antitumor agents

Publications (1)

Publication Number Publication Date
BR0104352A true BR0104352A (pt) 2002-01-02

Family

ID=22658023

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0104352-8A BR0104352A (pt) 2000-02-02 2001-02-02 Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais

Country Status (20)

Country Link
US (3) US6596737B2 (pt)
EP (1) EP1165551B1 (pt)
JP (1) JP2003522173A (pt)
KR (1) KR20020000159A (pt)
CN (1) CN1362959A (pt)
AT (1) ATE401325T1 (pt)
AU (1) AU783422B2 (pt)
BR (1) BR0104352A (pt)
CA (1) CA2368541A1 (pt)
CZ (1) CZ20013520A3 (pt)
DE (1) DE60134814D1 (pt)
HK (1) HK1047936A1 (pt)
HU (1) HUP0200721A3 (pt)
IL (1) IL145640A (pt)
MX (1) MXPA01009921A (pt)
NO (1) NO20014760L (pt)
NZ (1) NZ514407A (pt)
PL (1) PL350331A1 (pt)
WO (1) WO2001057033A1 (pt)
ZA (1) ZA200108053B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638973B2 (en) * 2000-02-02 2003-10-28 Fsu Research Foundation, Inc. Taxane formulations
CN1362959A (zh) * 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C10氨基甲酰氧基取代的紫衫烷抗肿瘤剂
CN1712399B (zh) * 2004-06-24 2010-08-11 中国医学科学院药物研究所 紫杉醇和免疫增强剂胞壁酰二肽共轭物的制备及用途
CA2647564C (en) * 2006-04-03 2016-08-30 Pharmatherm Chemicals Inc. Thermal extraction method and product
CN103183724B (zh) 2010-05-27 2015-01-14 深圳信立泰药业股份有限公司 多西紫杉醇共缀物的制备方法
JP6959096B2 (ja) * 2017-10-13 2021-11-02 エイブリック株式会社 充放電制御回路及びこれを備えたバッテリ装置

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
FR2679230B1 (fr) 1991-07-16 1993-11-19 Rhone Poulenc Rorer Sa Nouveaux derives d'analogues du taxol, leur preparation et les compositions qui les contiennent.
US5227400A (en) 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5350866A (en) 1991-09-23 1994-09-27 Bristol-Myers Squibb Company 10-desacetoxytaxol derivatives
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5430160A (en) 1991-09-23 1995-07-04 Florida State University Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
US5714513A (en) 1991-09-23 1998-02-03 Florida State University C10 taxane derivatives and pharmaceutical compositions
DE69329304T2 (de) 1992-01-15 2001-01-04 E.R. Squibb & Sons, Inc. Enzymatische Verfahren zur Resolution von Enantiomeren-Mischungen nützlich wie Zwischenprodukte zur Herstellung von Taxanen
US5272171A (en) 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
FR2691460B1 (fr) 1992-05-21 1994-07-22 Rhone Poulenc Rorer Sa Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
CA2109861C (en) 1992-12-04 1999-03-16 Shu-Hui Chen 6,7-modified paclitaxels
DE69424166T2 (de) 1993-06-11 2000-10-05 Pharmacia & Upjohn Co., Kalamazoo Delta 6, 7-taxolen, antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
IL109926A (en) 1993-06-15 2000-02-29 Bristol Myers Squibb Co Methods for the preparation of taxanes and microorganisms and enzymes utilized therein
TW397866B (en) 1993-07-14 2000-07-11 Bristol Myers Squibb Co Enzymatic processes for the resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes
US6100411A (en) 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
AU4133096A (en) 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
FR2732342B1 (fr) * 1995-04-03 1997-04-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2732968B1 (fr) 1995-04-14 1997-05-16 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5780653A (en) 1995-06-07 1998-07-14 Vivorx Pharmaceuticals, Inc. Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
CA2231837A1 (en) 1995-09-13 1997-03-20 Florida State University Radiosensitizing taxanes and their pharmaceutical preparations
CA2253513A1 (en) 1996-05-06 1997-11-13 Florida State University 1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
BR9710366A (pt) * 1996-07-15 1999-08-17 Yakult Honsha Kk Derivados de taxane e drogas que os contêm
US5811452A (en) 1997-01-08 1998-09-22 The Research Foundation Of State University Of New York Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
JPH1192468A (ja) 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
WO1999032473A1 (fr) 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Derives de taxane
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤
KR20010111580A (ko) 2000-02-02 2001-12-19 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 개선된 용해도를 갖는 탁산 제형물
US6638973B2 (en) * 2000-02-02 2003-10-28 Fsu Research Foundation, Inc. Taxane formulations
CN1362959A (zh) * 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C10氨基甲酰氧基取代的紫衫烷抗肿瘤剂
GB2370649B (en) * 2000-11-09 2003-06-25 Toppan Printing Co Ltd Measurement of rate of transmission of a vapour through a sample

Also Published As

Publication number Publication date
EP1165551B1 (en) 2008-07-16
MXPA01009921A (es) 2003-08-01
CA2368541A1 (en) 2001-08-09
HK1047936A1 (zh) 2003-03-14
KR20020000159A (ko) 2002-01-04
CN1362959A (zh) 2002-08-07
US20040034230A1 (en) 2004-02-19
ZA200108053B (en) 2003-12-01
US7230013B2 (en) 2007-06-12
JP2003522173A (ja) 2003-07-22
IL145640A0 (en) 2002-06-30
US6906088B2 (en) 2005-06-14
ATE401325T1 (de) 2008-08-15
NO20014760L (no) 2001-11-30
CZ20013520A3 (cs) 2002-03-13
IL145640A (en) 2007-02-11
PL350331A1 (en) 2002-12-02
US6596737B2 (en) 2003-07-22
DE60134814D1 (de) 2008-08-28
AU3331301A (en) 2001-08-14
HUP0200721A3 (en) 2005-02-28
NO20014760D0 (no) 2001-10-01
HUP0200721A2 (hu) 2002-07-29
NZ514407A (en) 2004-12-24
EP1165551A1 (en) 2002-01-02
AU783422B2 (en) 2005-10-27
US20050182098A1 (en) 2005-08-18
WO2001057033A1 (en) 2001-08-09
US20020077341A1 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
BG105967A (en) C(7) ester substituted taxanes and their use as antitumor agents
DK1414828T3 (da) Antitumoranaloger
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
IL145639A0 (en) C10 heterosubstituted acetate taxanes as antitumor agents
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
BR0104352A (pt) Taxanos substituìdos por c10 carbamoilóxi como agentes antitumorais
BR0104353A (pt) Taxanos heterosubstituìdos com acetato c7 como agentes antitumor
BR0104779A (pt) Taxanos substituìdos com carbonato c10 comoagentes antitumor
BR0104355A (pt) Taxanos substituìdos por c7 carbamoilóxi como agentes antitumor
BR0104351A (pt) Taxanos substituìdos com carbonato c7 como agentes antitumor
DE602006013953D1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl-y-aminopropyl-azalide mit antimalaria-aktivität
BR0104354A (pt) Taxanos substituìdos com éster c10
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
YU83903A (sh) Farmaceutske kombinacije zasnovane na derivatima piridoindolona
BRPI0410638A (pt) derivados de azitromicina
ATE282611T1 (de) Stolonoxide
BR0106693A (pt) Taxanos substituìdos com éster de c10
ATE261962T1 (de) Benzonaphtyridin-1,8 derivate

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A., 9A., 10A. E 11A. ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011.